Published Date: 16 Feb 2023
Study documents huge financial costs of breast cancer treatment for women in high and low/middle income countries and offers opportunities for intervention.
Read Full NewsIn a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.
A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
1.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
2.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
3.
The New Canadian Guidelines for Drinking at High Risk, AUD.
4.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
5.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
1.
A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer
2.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
3.
The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation